Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
AI in biopharma requires strong data, human oversight
12+ hour, 50+ min ago (552+ words) An executive from Thermo Fisher discusses how AI stands to transform the industry without compromising the need for human operators. Use cases for AI tools continue to evolve in biopharmaceutical development and manufacturing. The technology already has tremendous influence on…...
Synthetic CAR T: The future of advanced cell therapies?
1+ day, 11+ hour ago (830+ words) A consultant at eXmoor discusses the evolution of CAR T therapies and how exciting innovations may change the advanced therapy landscape forever. A great contradiction exists in the world of cell and gene therapies (CGTs). While developments in advanced modalities…...
Human-in-the-Loop Models for AI in Biopharma Commercial Analytics
1+ week, 12+ hour ago (1123+ words) The future of biopharmaceutical commercial analytics is not agentic AI versus humans, but governed collaboration between the two. Human-in-the-loop models provide a scalable path forward by combining the speed and breadth of automation with the judgment, accountability, and trust required…...
Vendor Governance Is a Quality System
2+ week, 3+ day ago (970+ words) Vendor oversight cannot be treated only as relationship management or periodic status review: It has to function as part of a quality system. Organizations can strengthen that capability by moving beyond status-based oversight and focusing on specific controls to see…...
Expert tips for launching pharma products in Europe
2+ week, 12+ hour ago (531+ words) An industry expert shares important tips with the Pharma Conversation Podcast about how best to approach a product launch in Europe. Launching a pharmaceutical product in Europe is one of the most strategically significant and operationally complex moves a biotech…...
Eli Lilly and Amplitude Therapeutics partner on RNA vaccines
2+ week, 5+ day ago (293+ words) The collaboration will focus on using trans-amplifying RNA to target infectious diseases. Trans-amplifying RNA (taRNA) describes RNA that can replicate itself, usually from a viral source. The benefit is that, theoretically, a large immune response can be generated with minimal…...
Yapan Bio to become Piramal subsidiary following acquisition
3+ week, 11+ hour ago (221+ words) Yapan Bio’s range of services will help to advance PPL’s biologic development and manufacturing. According to Yapan Bio’s website, the company specializes in gene therapy, monoclonal antibodies (mAbs), and therapeutic proteins. It also claims expertise in process development and optimization,…...
WuXI XDC announces GMP release of Singapore DS production line
3+ week, 1+ day ago (333+ words) The CEO called the achievement a “major milestone” for his company’s global manufacturing strategy. Contract development and manufacturing organization (CDMO) WuXi XDC announced the GMP release of its BCM3 dual-function production line for antibody intermediates and drug substances at its site…...
Decentralized Apheresis for Cell and Gene Therapy Accessibility
3+ week, 1+ day ago (481+ words) Although cell and gene therapies are gaining traction commercially, the distance between patients and specialized collection centers threatens to exacerbate current problems with accessibility. The writers demonstrate how decentralized apheresis offers a practical path for addressing concerns with access and…...
Webinar Cell Line Engineering and Expression Optimization
4+ week, 17+ hour ago (32+ words) Date: Aug 26, 2026 Time: 11:00 am EDT Download webinar documents here. GeoVax CEO: Preparedness is measured by what doesn’t happen CASTL and NIBRT team to bring biomanufacturing training to Canada...